Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Scheiflinger

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Blood|February 21, 2004
Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpuraChristoph Klaus, Barbara Plaimauer, Jan-Dirk Studt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2015
Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic PurpuraClaudia Tersteeg, Alexandra Schiviz, Simon F De Meyer, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2019
Temperature-dependent irreversible conformational change of recombinant ADAMTS13 upon metal ion chelationHanspeter Rottensteiner, Stefan Kaufmann, Anna Rathgeb, et al.
Blood|July 12, 2003
Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpuraFriedrich Scheiflinger, Paul Knöbl, Bettina Trattner, et al.
Analytical Chemistry|September 16, 2015
Shear-Dependent Interactions of von Willebrand Factor with Factor VIII and Protease ADAMTS 13 Demonstrated at a Single Molecule Level by Atomic Force MicroscopyKlaus Bonazza, Hanspeter Rottensteiner, Gerald Schrenk, et al.
Analytical and Bioanalytical Chemistry|May 24, 2015
Ca(2+) concentration-dependent conformational change of FVIII B-domain observed by atomic force microscopyKlaus Bonazza, Hanspeter Rottensteiner, Gerald Schrenk, et al.
Blood|September 16, 2004
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobinJan-Dirk Studt, Johanna A Kremer Hovinga, Gerhard Antoine, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2011
Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpuraS Ferrari, P Knöbl, V Kolovratova, et al.
Thrombosis and Haemostasis|November 27, 2015
Role of exosite binding modulators in the inhibition of Fxa by TFPISameera Peraramelli, Stella Thomassen, Alexandra Heinzmann, et al.
Pharmaceutical Research|March 20, 2015
A Flow-Cytometry-Based Approach to Facilitate Quantification, Size Estimation and Characterization of Sub-visible Particles in Protein SolutionsChristian Lubich, Mantas Malisauskas, Thomas Prenninger, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Blood|February 21, 2004
Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpuraChristoph Klaus, Barbara Plaimauer, Jan-Dirk Studt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2015
Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic PurpuraClaudia Tersteeg, Alexandra Schiviz, Simon F De Meyer, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2019
Temperature-dependent irreversible conformational change of recombinant ADAMTS13 upon metal ion chelationHanspeter Rottensteiner, Stefan Kaufmann, Anna Rathgeb, et al.
Blood|July 12, 2003
Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpuraFriedrich Scheiflinger, Paul Knöbl, Bettina Trattner, et al.
Analytical Chemistry|September 16, 2015
Shear-Dependent Interactions of von Willebrand Factor with Factor VIII and Protease ADAMTS 13 Demonstrated at a Single Molecule Level by Atomic Force MicroscopyKlaus Bonazza, Hanspeter Rottensteiner, Gerald Schrenk, et al.
Analytical and Bioanalytical Chemistry|May 24, 2015
Ca(2+) concentration-dependent conformational change of FVIII B-domain observed by atomic force microscopyKlaus Bonazza, Hanspeter Rottensteiner, Gerald Schrenk, et al.
Blood|September 16, 2004
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobinJan-Dirk Studt, Johanna A Kremer Hovinga, Gerhard Antoine, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2011
Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpuraS Ferrari, P Knöbl, V Kolovratova, et al.
Thrombosis and Haemostasis|November 27, 2015
Role of exosite binding modulators in the inhibition of Fxa by TFPISameera Peraramelli, Stella Thomassen, Alexandra Heinzmann, et al.
Pharmaceutical Research|March 20, 2015
A Flow-Cytometry-Based Approach to Facilitate Quantification, Size Estimation and Characterization of Sub-visible Particles in Protein SolutionsChristian Lubich, Mantas Malisauskas, Thomas Prenninger, et al.
Pageof 9